{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:58:42Z","timestamp":1767992322734,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03031","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T12:17:26Z","timestamp":1547036246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality"],"prefix":"10.3389","volume":"9","author":[{"given":"Shinya","family":"Rai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Luis","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.14488","article-title":"Guideline for the investigation and management of eosinophilia","volume":"176","author":"Butt","year":"2017","journal-title":"Br J Haematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fmed.2017.00240","article-title":"Clinical and biological markers in hypereosinophilic syndromes","volume":"4","author":"Khoury","year":"2017","journal-title":"Front Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fmed.2017.00216","article-title":"(A Critical Appraisal of) Classification of hypereosinophilic disorders","volume":"4","author":"Kahn","year":"2017","journal-title":"Front Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cbi.2009.10.009","article-title":"The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms","volume":"184","author":"Vardiman","year":"2010","journal-title":"Chem Biol Interact."},{"key":"B8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.blre.2018.04.008","article-title":"Current status and trends in the diagnostics of AML and MDS","volume":"32","author":"Shumilov","year":"2018","journal-title":"Blood Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.leukres.2018.06.012","article-title":"Morphologic dysplasia in Myelodysplastic Syndromes: how accurate are morphologists?","volume":"71","author":"Bennett","year":"2018","journal-title":"Leuk Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/ijlh.12826","article-title":"Clonal cytogenetic abnormalities of undetermined significance","volume":"40","author":"Tang","year":"2018","journal-title":"Int J Lab Hematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000488712","article-title":"The molecular pathology of myelodysplastic syndrome","author":"Haferlach","year":"2018","journal-title":"Pathobiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/102453311X12940641877966","article-title":"Cytogenetic abnormalities in myelodysplastic syndrome: an overview","volume":"16","author":"Kawankar","year":"2011","journal-title":"Hematology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ejh.13092","article-title":"The genetic and molecular pathogenesis of myelodysplastic syndromes","volume":"101","author":"Shallis","year":"2018","journal-title":"Eur J Haematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2015034","DOI":"10.4084\/mjhid.2015.034","article-title":"Rare cytogenetic abnormalities in myelodysplastic syndromes","volume":"7","author":"Bacher","year":"","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/sj.leu.2404619","article-title":"Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms","volume":"21","author":"Sanada","year":"2007","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0609.2009.01392.x","article-title":"Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations","volume":"84","author":"Caramazza","year":"2010","journal-title":"Eur J Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cancergencyto.2009.04.013","article-title":"Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical\/pathologic features compared to\u22127\/del(7q) MDS","volume":"193","author":"Slovak","year":"2009","journal-title":"Cancer Genet Cytogenet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/17474086.2016.1257936","article-title":"Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists","volume":"9","author":"Duployez","year":"2016","journal-title":"Expert Rev Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00277-016-2691-1","article-title":"Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study","volume":"95","author":"Byun","year":"2016","journal-title":"Ann Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.path.2015.10.004","article-title":"Genetic testing in acute myeloid leukemia and myelodysplastic syndromes","volume":"9","author":"Nardi","year":"2016","journal-title":"Surg Pathol Clin."},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1096-8652(200007)64:3<161::AID-AJH4>3.0.CO;2-Q","article-title":"Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies","volume":"64","author":"Pedersen","year":"2000","journal-title":"Am J Hematol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/1097-0142(19900315)65:6<1350::AID-CNCR2820650617>3.0.CO;2-J","article-title":"The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication","volume":"65","author":"Horiike","year":"1990","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ajh.23230","article-title":"Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications","volume":"87","author":"Hussain","year":"2012","journal-title":"Am J Hematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1182\/blood-2002-03-0947","article-title":"Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia","volume":"101","author":"Matsushima","year":"2003","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11899-018-0448-8","article-title":"Diagnosis and novel approaches to the treatment of hypereosinophilic syndromes","volume":"13","author":"Dispenza","year":"2018","journal-title":"Curr Hematol Malig Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ajh.24196","article-title":"World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gotlib","year":"2015","journal-title":"Am J Hematol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1365-2141.2003.04458.x","article-title":"Cytogenetic and molecular genetic aspects of eosinophilic leukaemias","volume":"122","author":"Bain","year":"2003","journal-title":"Br J Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0165-4608(96)00391-3","article-title":"Deletion of the long arm of chromosome 7 in myelomonocytic leukemia with bone marrow eosinophilia","volume":"97","author":"Davidovitz","year":"1997","journal-title":"Cancer Genet Cytogenet."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T12:17:28Z","timestamp":1547036248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2018.03031"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03031","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"article-number":"3031"}}